Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.

Ítems similars

• Cystic fibrosis mutations delta F508 and G542X in Jewish patients.
  per: Lerer, I, et al.
  Publicat: (1992)
• Carrier screening in individuals of Ashkenazi Jewish descent
  per: Gross, Susan J., et al.
  Publicat: (2008)
• The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
  per: Hubert, A, et al.
  Publicat: (1999)
• The 28-kb Deletion Spanning D15S63 Is a Polymorphic Variant in the Ashkenazi Jewish Population
  per: Silverstein, Shira, et al.
  Publicat: (2001)
• Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
  per: Dolitsky, Shelley, et al.
  Publicat: (2020)